Portage Biotech Announces Letter of Intent With Immunova for an Option To Acquire iOx Therapeutics, Ltd
UF startup Immunova, LLC, a private Connecticut-based biotechnology company, has entered into a Letter of Intent with Portage Biotech, Inc. to advance its novel immuno-oncology therapies for cancer treatment.
UF Civil Engineering Professor To Shape Building Policy As New Jefferson Science Fellow
UF researcher David O. Prevatt has joined the 2024-2025 Jefferson Science Fellowship with the U.S. Department of State, where he will apply his expertise to improve the resilience of U.S. diplomatic facilities worldwide against natural hazards.
Rob Ferl and Anna-Lisa Paul Fall 2024 Commencement Speech
At the 2024 UF Fall Commencement, Dr. Rob Ferl and Dr. Anna-Lisa Paul delivered an inspiring speech emphasizing the power of collaboration and shared journeys.
University of Florida To Acquire One of the World’s Most Powerful Supercomputers
The University of Florida Board of Trustees approved investing $24 million to acquire a more advanced version of UF’s HiPerGator supercomputer.
UF Presents the 2024 Win Phillips Town Gown Relations Awards
UF presented three Win Phillips Town Gown Relations Awards. Among the recipients, UF researcher Lily Elefteriadou was honored for her pioneering work in advancing transportation innovations through the I-STREET Living Lab.
UF Microbiome Expert Named UF Distinguished Professor
Christian Jobin, Ph.D., who leads innovative research on how the microbiome affects cancer, inflammation, and drug responses, has been named a UF Distinguished Professor, which is the highest faculty honor awarded at UF.
A Bacterial Toxin That Promotes Colorectal Cancer Metastasis
UF researcher Christian Jobin's study suggests that microbial cells in the gut can influence human health, with some contributing to colorectal cancer metastasis.
Atsena Therapeutics Announces Dosing Completed in Part A of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced dosing has been completed in Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
UF Moves Forward With Site for New Campus in Jacksonville
UF announced plans for a new Jacksonville campus, which will serve as a hub for research in health and semiconductor technology, offer advanced graduate programs, and foster innovation through the Florida Semiconductor Institute’s focus on R&D and workforce development.
Dr. Christine Schmidt Elected to Board of Directors of the Academy of Science, Engineering and Medicine of Florida
UF researcher Christine Schmidt has been elected to the Board of Directors of the Academy of Science, Engineering, and Medicine of Florida (ASEMFL).
